Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RCL vs GSK✓SelectedUSD · GSKRCL vs GSK performance historyLatest closeAs of-2.20%11/20
Stock and ETF performance explorer

RCL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+302.8%
GSK return
+97.4%
Excess return
+205.4%
Maximum drawdown
-83.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%-0.1%-2.1%-2.1%
7D-8.3%-5.3%-3.0%-6.2%
30D+2.8%-3.7%+6.4%+4.3%
3M+3.7%-7.3%+10.9%+6.7%
6M+18.1%-4.2%+22.3%+19.5%
YTD+8.1%+0.9%+7.2%+6.9%
1Y+19.7%+7.3%+12.4%+15.5%
3Y+189.8%+52.7%+137.1%+124.7%
5Y+281.1%+40.1%+241.0%+202.8%
All+302.8%+97.4%+205.4%+190.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling